Status:
NOT_YET_RECRUITING
Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis
Lead Sponsor:
Nantes University Hospital
Conditions:
Hypersensitivity Pneumonitis
Eligibility:
All Genders
18+ years
Brief Summary
Hypersensitivity pneumonitis (HP) is a diffuse infiltrative pneumonitis (DIP) of immuno-allergic origin, caused by exposure to one or more antigenic substances of organic origin, in genetically predis...
Detailed Description
Patients will be prospectively recruited as incidental cases during multidisciplinary discussions of diffuse interstitial lung disease organized on a regular monthly basis between university hospitals...
Eligibility Criteria
Inclusion
- Patient of legal age,
- French-speaking patient,
- Patient with a diagnosis of fibrosing PHS following a multidisciplinary discussion of diffuse interstitial lung disease hypersensitivity pneumonitis .
- Patient who had received an information note presenting the study and who had not expressed opposition to participating in this research.
Exclusion
- Opposition of the patient to participate in the study,
- Patient under guardianship, curatorship or safeguard of justice,
- Patients who have moved within the last 12 months, or who plan to move within the next 6 months,
- Patients who have already had a visit from the indoor environment medical advisor.
Key Trial Info
Start Date :
December 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 12 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05988437
Start Date
December 12 2023
End Date
June 12 2026
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, Loire-Atlantique, France, 44093